Jazz Pharmaceuticals, Inc. (JAZZ) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for JAZZ. 13F holdings as of 2026-09-30.
In 13F filings for the quarter ended September 30, 2026, 226 institutions reported holding JAZZ, with 36.0 million shares worth $8.3 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 6,454,463 | $1.5B | INCREASED |
| FMR | 5,543,812 | $1.3B | INCREASED |
| Vanguard | 3,479,975 | $806M | INCREASED |
| Lsv Asset Management | 2,135,935 | $495M | DECREASED |
| State Street | 2,067,988 | $479M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Bruce C Cozadd (Director) | EXERCISE | 85,766 | $12M | 2026-11-06 |
| Bruce C Cozadd (Director) | EXERCISE | 734 | $100K | 2026-11-06 |
| Bruce C Cozadd (Director) | SELL | 5,923 | $1M | 2026-11-06 |
| Bruce C Cozadd (Director) | SELL | 24,483 | $6M | 2026-11-06 |
| Bruce C Cozadd (Director) | SELL | 10,688 | $3M | 2026-11-06 |
Full institutional holdings, insider history, and congressional trades for Jazz Pharmaceuticals, Inc. on SentiSense.